UCHL1 inhibition could also be a potential treatment for several types of other cancers where UCHL1 is frequently overexpressed, including prostate cancer [112], non-small cell lung carcinoma [113], pancreatic cancer [114], leukemia [26], colorectal cancer [33] and medullary thyroid carcinoma [115]. This evidence concerns the gene UCHL1 and colorectal cancer.